Login to Your Account

Ampliphi $18M round sets stage for bacteriophage

By Marie Powers
Staff Writer

Monday, December 16, 2013

With the goal of delivering early clinical data over the next 18 months to demonstrate the validity of its scientific approach and move from the pink sheets to a registered exchange, Ampliphi Biosciences Corp. inked agreements with a group of investors for an $18 million private placement.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription